Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
HUBLOT AND DANIEL ARSHAM UNVEIL THE MP-17 ARSHAM SPLASH : A FLUID EVOLUTION OF ARTISTIC HOROLOGY
SINGAPORE, Oct. 9, 2025 /PRNewswire/ -- Pioneering Swiss luxury watchmaker Hublot has announced…
